Oxycodone HCL-Acetaminophen Tablets
Awarded on September 29, 2022. Full description on SAM.gov.
Description
SPE2D2-22-D-0150 P00009 to invoke Option Year 4
SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).
SPE2D2-22-D-0150 P00007 to invoke Option Year 3
SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders.
SPE2D2-22-D-0150 P00005 to invoke Option Year 2
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Overview
Award Overview
Award Number
SPE2D222D0150
Award Amount (SAM.gov award notice)
$7.3M
Award Date
Sep 29, 2022
Awardee
Awardee UEI
SJ9MSB1UXGL8
Awardee CAGE Code
84GK4
Awardee Address
Webster Groves, MO 63119, UNITED STATES
Original Solicitation
Notice ID: 4aca076cbdbf474ea4f758f9b7d61f50
Posted Date: Sep 2, 2026
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (11)
- Download
SF30_SPE2D222D0150P00008.PDF
178 KBAdded in Award Notice version 7Posted - Download
SF30_SPE2D222D0150P00009.PDF
25 KBAdded in Award Notice version 7Posted - Download
SPE2D222D0150 MOD P00007 SIGNED.pdf
116 KBAdded in Award Notice version 6Posted - Download
SF30_SPE2D222D0150P00006.PDF
197 KBAdded in Award Notice version 6Posted - Download
Modification P00005 - Signed.PDF
25 KBAdded in Award Notice version 5Posted - Download
SPE2D222D0150 P00003 Option Year 1.PDF
25 KBAdded in Award Notice version 4Posted - Download
Signed SPE2D222D0150 P00002 Oxycodone HCL-Ace.pdf
1016 KBAdded in Award Notice version 3Posted - Download
SPE2D222D0150 P00001.pdf
688 KBAdded in Award Notice version 3Posted - Download
SF30_SPE2D221R01140001.PDF
18 KBAdded in Solicitation version 3Posted - Download
Signed Oxycodone HCL-Acetaminophen Award SPE2D2-22-D-0150.pdf
843 KBAdded in Award Notice version 2Posted - Download
Oxycodone HCL-Acetaminophen Solicitation- SPE2D221R0114.pdf
1.6 MBAdded in Solicitation version 2Posted
Lifecycle
- 1Version 1Solicitation
Oxycodone HCL-Acetaminophen Tablets
- 2Version 2Award Notice
Type changed from Solicitation to Award Notice
Oxycodone HCL-Acetaminophen Tablets
- 3Version 3Award Notice
Oxycodone HCL-Acetaminophen Tablets
- 4Version 4Award Notice
Oxycodone HCL-Acetaminophen Tablets
- 5Version 5Award Notice
Oxycodone HCL-Acetaminophen Tablets
- 6Version 6Award Notice
Oxycodone HCL-Acetaminophen Tablets
- 7Version 7Award NoticeCurrent
Oxycodone HCL-Acetaminophen Tablets
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
Additional Details
Solicitation Number
SPE2D221R0114
Archive Date
Dec 31, 2027
Office Address
PHILADELPHIA, PA, 19111